P/E ratio for National Health Investors (NHI)
P/E ratio as of April 2024 (TTM): 24.7
According to National Health Investors's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.747. At the end of 2022 the company had a P/E ratio of 35.5.
P/E ratio history for National Health Investors from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 35.5 | 50.82% |
| 2021 | 23.6 | 40.97% |
| 2020 | 16.7 | -24.54% |
| 2019 | 22.1 | 8.16% |
| 2018 | 20.5 | 5.92% |
| 2017 | 19.3 | 1.11% |
| 2016 | 19.1 | 24.05% |
| 2015 | 15.4 | -33.04% |
| 2014 | 23.0 | 53.01% |
| 2013 | 15.0 | -13% |
| 2012 | 17.3 | 15.17% |
| 2011 | 15.0 | -16.31% |
| 2010 | 17.9 | 12.5% |
| 2009 | 15.9 | 20.32% |
| 2008 | 13.3 | 65.28% |
| 2007 | 8.02 | -39.51% |
| 2006 | 13.3 | 0.06% |
| 2005 | 13.2 | -6.95% |
| 2004 | 14.2 | -9.61% |
| 2003 | 15.7 | 6.74% |
| 2002 | 14.8 | -106.98% |
| 2001 | -211 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 National Healthcare
NHC | 43.9 | 77.19% | 🇺🇸 USA |
 Saul Centers BFS | 21.9 | -11.59% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.